Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Class A Common Stock, $0.00001 par value per share
-
Shares outstanding
-
4,564,846
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
152,228,034
-
Shares change
-
+24,647,929
-
Total reported value, excl. options
-
$1,164,429,792
-
Value change
-
+$189,175,887
-
Put/Call ratio
-
113%
-
Number of buys
-
126
-
Number of sells
-
-55
-
Price
-
$7.65
Significant Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) as of Q3 2023
220 filings reported holding RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share as of Q3 2023.
RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 152,228,034 shares
.
Largest 10 shareholders include BAILLIE GIFFORD & CO (24,551,409 shares), VANGUARD GROUP INC (15,506,834 shares), BlackRock Inc. (11,856,954 shares), STATE STREET CORP (11,757,088 shares), FMR LLC (10,689,532 shares), Kinnevik AB (publ) (10,405,668 shares), MIC Capital Management UK LLP (8,451,758 shares), ARK Investment Management LLC (6,876,598 shares), Data Collective IV GP, LLC (5,941,120 shares), and Sumitomo Mitsui Trust Holdings, Inc. (3,523,124 shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.